Determination of peptide oligomerization state using rapid photochemical crosslinking

Methods in Molecular Biology

Volumn 299, Issue , 2005, Pages 11-18

  Vollers, Sabrina S ^a   Teplow, David B ^a   Bitan, Gal ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Amyloid protein; Crosslinking; Oligomer; Oligomerization state; Protein assembly

Indexed keywords

AMYLOID BETA PROTEIN; FREE RADICAL; POLYPEPTIDE;

OLIGOMERIZATION; PHOTOCHEMISTRY; PROTEIN CROSS LINKING; PROTEIN STRUCTURE;

EID: 22844449646     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1385/1-59259-874-9:011     Document Type: Chapter

References (17)

1. Kirkitadze, M. D., Bitan, G., and Teplow, D. B. (2002) Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J. Neurosci. Res. 69, 567-577.
2. Koo, E. H., Lansbury, P. T., and Kelly, J. W. (1999) Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc. Natl. Acad. Sci. USA 96, 9989-9990.
3. Selkoe, D. J. (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, A23-A31.
4. Klein, W. L., Krafft, G. A., and Finch, C. E. (2001) Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24, 219-224.
5. Walsh, D. M., Klyubin, I., Fadeeva, J. V., et al. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
6. Baskakov, I. V., Legname, G., Baldwin, M. A., Prusiner, S. and Cohen, F. E. (2002) Pathway complexity of prion protein assembly into amyloid. J. Biol. Chem. 277, 21140-21148.
7. Lashuel, H. A., Petre, B. M., Wall, J., et al. (2002) a-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J. Mol. Biol. 322, 1089-1102.
8. Sanchez, I., Mahlke, C., and Yuan, J. Y. (2003) Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421, 373-379.
9. Roher, A. E., Chaney, M. O., Kuo, Y. M., et al. (1996) Morphology and toxicity of Aβ(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 271, 20631-20635.
10. Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., and Teplow, D. B. (1997) Amyloid β-protein fibrillogenesis—detection of a protofibrillar intermediate. J. Biol. Chem. 272, 22364-22372.
11. Lomakin, A., Chung, D. S., Benedek, G. B., Kirschner, D. A., and Teplow, D. B. (1996) On the nucleation and growth of amyloid β-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. USA 93, 1125-1129.
12. Garzon-Rodriguez, W., Sepulveda-Becerra, M., Milton, S., and Glabe, C. G. (1997) Soluble amyloid Aβ-(1-40) exists as a stable dimer at low concentrations. J. Biol. Chem. 272, 21037-21044.
13. Huang, T. H., Yang, D. S., Plaskos, N. P., et al. (2000) Structural studies of soluble oligomers of the Alzheimer β-amyloid peptide. J. Mol. Biol. 297, 73-87.
14. Zagorski, M. G., Shao, H., Ma, K., et al. (2000) Aβ(1-40) and Aβ(1-42) adopt remarkably stable monomeric and extended structures in water solution at neutral pH. Neurobiol. Aging 21, S10-S11 (Abstract 48).
15. Bitan, G., Lomakin, A., and Teplow, D. B. (2001) Amyloid β-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J. Biol. Chem. 276, 35176-35184.
16. Fancy, D. A. and Kodadek, T. (1999) Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light. Proc. Natl. Acad. Sci. USA 96, 6020-6024.
17. Fancy, D. A., Denison, C., Kim, K., et al. (2000) Scope, limitations and mechanistic aspects of the photo-induced cross-linking of proteins by water-soluble metal complexes. Chem. Biol. 7, 697-708.